Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is increasing in prevalence both in nosocomial and in community settings. Treatment of such infections, particularly in the central nervous system (CNS), is problematic, as available options are limited. Linezolid is a new antibiotic with activity against Gram-positive cocci, including MRSA, and has good penetration into the cerebrospinal fluid. To our knowledge, there are only three case reports of successful treatment of CNS infections caused by MRSA with linezolid; we report herein a fourth such case. Clinical trials to address the role of linezolid in CNS infections are urgently needed.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kessler, A.T., Kourtis, A.P. Treatment of Meningitis Caused by Methicillin-Resistant Staphylococcus aureus with Linezolid. Infection 35, 271–274 (2007). https://doi.org/10.1007/s15010-007-6211-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-007-6211-z